Intuitive Surgical (ISRG) Cash & Equivalents (2009 - 2026)

Intuitive Surgical has reported Cash & Equivalents for 18 years, with the latest figure at $2.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 23.33% year-over-year to $2.0 billion; the trailing twelve-month figure through Mar 2026 stood at $2.0 billion (down 23.33% YoY), and the FY2025 full-year result was $3.4 billion, up 63.3% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $2.0 billion, down from $3.4 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $3.6 billion in Q3 2023, with the low at $1.1 billion in Q1 2022.
• Average Cash & Equivalents over 5 years is $2.5 billion, with a median of $2.6 billion recorded in 2025.
• Year-over-year, Cash & Equivalents surged 134.2% in 2023 and sank 32.08% in 2024.
• Tracing ISRG's Cash & Equivalents over 5 years: stood at $1.6 billion in 2022, then jumped by 75.19% to $2.8 billion in 2023, then decreased by 25.55% to $2.1 billion in 2024, then surged by 63.3% to $3.4 billion in 2025, then slumped by 40.42% to $2.0 billion in 2026.
• The last three Cash & Equivalents figures came in at $2.0 billion (Q1 2026), $3.4 billion (Q4 2025), and $2.8 billion (Q3 2025), per Business Quant data.

Peer Comparison